Bee venom processes human skin lipids for presentation by CD1a

DSpace/Manakin Repository

Bee venom processes human skin lipids for presentation by CD1a

Citable link to this page


Title: Bee venom processes human skin lipids for presentation by CD1a
Author: Bourgeois, Elvire A.; Subramaniam, Sumithra; Cheng, Tan-Yun; De Jong, Annemieke; Layre, Emilie; Ly, Dalam; Salimi, Maryam; Legaspi, Annaliza; Modlin, Robert L.; Salio, Mariolina; Cerundolo, Vincenzo; Moody, D. Branch; Ogg, Graham

Note: Order does not necessarily reflect citation order of authors.

Citation: Bourgeois, E. A., S. Subramaniam, T. Cheng, A. De Jong, E. Layre, D. Ly, M. Salimi, et al. 2015. “Bee venom processes human skin lipids for presentation by CD1a.” The Journal of Experimental Medicine 212 (2): 149-163. doi:10.1084/jem.20141505.
Full Text & Related Files:
Abstract: Venoms frequently co-opt host immune responses, so study of their mode of action can provide insight into novel inflammatory pathways. Using bee and wasp venom responses as a model system, we investigated whether venoms contain CD1-presented antigens. Here, we show that venoms activate human T cells via CD1a proteins. Whereas CD1 proteins typically present lipids, chromatographic separation of venoms unexpectedly showed that stimulatory factors partition into protein-containing fractions. This finding was explained by demonstrating that bee venom–derived phospholipase A2 (PLA2) activates T cells through generation of small neoantigens, such as free fatty acids and lysophospholipids, from common phosphodiacylglycerides. Patient studies showed that injected PLA2 generates lysophospholipids within human skin in vivo, and polyclonal T cell responses are dependent on CD1a protein and PLA2. These findings support a previously unknown skin immune response based on T cell recognition of CD1a proteins and lipid neoantigen generated in vivo by phospholipases. The findings have implications for skin barrier sensing by T cells and mechanisms underlying phospholipase-dependent inflammatory skin disease.
Published Version: doi:10.1084/jem.20141505
Other Sources:
Terms of Use: This article is made available under the terms and conditions applicable to Other Posted Material, as set forth at
Citable link to this page:
Downloads of this work:

Show full Dublin Core record

This item appears in the following Collection(s)


Search DASH

Advanced Search